Targeting DNA Repair

Giuseppe Curigliano1

  • 1Early Drug Development for Innovative Therapy Division, European Institute of Oncology, Via Ripamonti, 435 20141, Milan, Italy. Giuseppe.curigliano@ieo.it.

Insights

Genomic instability drives cancer development and progression. Understanding DNA damage response (DDR) pathways offers new avenues for personalized cancer medicine.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Genomic instability is a hallmark of most human cancers, contributing to tumor development and progression.
  • Multiple pathways, including DNA damage, centrosome amplification, telomere attrition, and epigenetic alterations, underlie genomic instability.
  • DNA repair mechanisms are crucial for cancer cell survival following DNA damage.

Purpose of the Study:

  • To explore the multifaceted nature of genomic instability in human cancers.
  • To investigate the molecular mechanisms of the DNA damage response (DDR).
  • To identify potential therapeutic strategies for personalized cancer medicine.

Main Methods:

  • Review of current literature on genomic instability and cancer.
  • Analysis of molecular pathways involved in DNA damage and repair.
  • Exploration of genetic interactions between DDR and other cellular pathways.

Main Results:

  • Genomic instability arises from diverse sources and is intrinsically linked to cancer progression.
  • Effective DNA repair allows cancer cells to persist despite DNA damage.
  • Failure in DNA damage response mechanisms is a key feature of genomic instability.

Conclusions:

  • Further understanding of DDR mechanisms and their interactions with other cellular pathways is essential.
  • Elucidating these molecular interactions will unlock new therapeutic opportunities for personalized cancer treatment.
  • Targeting genomic instability pathways holds promise for advancing cancer therapy.